Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Imdur — ISMOTIC
Application NDA017063 (NDA)
Imdur — ISMO
Application NDA019091 (NDA)
Imdur — IMDUR
Application NDA020225 (NDA)
Imdur — MONOKET
Application NDA020215 (NDA)
Cocaine HCl — GOPRELTO
Application NDA209963 (NDA)
Cocaine HCl — NUMBRINO
Application NDA209575 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)